In CML cells, SIAIS562055 promoted the active uptake of BCR–ABL inhibitors by upregulating the carnitine/organic cation transporter SLC22A4. The gene discussed is SLC22A4; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.